Acer Medical Inc.
Taipei Exchange 6857.TWO
Acer Medical Inc. Price to Sales Ratio (P/S) on January 14, 2025: 67.31
Acer Medical Inc. Price to Sales Ratio (P/S) is 67.31 on January 14, 2025, a -35.72% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
-
Acer Medical Inc. 52-week high Price to Sales Ratio (P/S) is 113.42 on February 20, 2024, which is 68.51% above the current Price to Sales Ratio (P/S).
-
Acer Medical Inc. 52-week low Price to Sales Ratio (P/S) is 67.23 on January 13, 2025, which is -0.12% below the current Price to Sales Ratio (P/S).
-
Acer Medical Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 88.22.
Key data
| Date | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield |
|---|
Market news
Loading...
Taipei Exchange: 6857.TWO
| CEO | Mr. Yin Xiong Xu |
| IPO Date | March 4, 2022 |
| Location | |
| Headquarters | No. 88, Section 1, Xintai 5th Road |
| Employees | 22 |
| Sector | Technology |
| Industries | |
Description
Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. It offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email